6.6 Conclusion
A number of diseases have been described as co-occurring with HS. The association may often occur by chance taking into account the prevalence of HS in the general population. The serendipitous observation of co-occurrence may however also reflect a causal relationship between the diseases, and thereby lead to a better aetiological or pathogenic understanding of both diseases. Taking all the suggested associations into account a very heterogeneous picture emerges, which does not allow hard conclusions to be made. This review of the literature strongly underlines the continued need for systematic observations in larger numbers of patients. The establishment of patient cohorts of sufficient size to allow longitudinal studies is therefore encouraged.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams BB. Co-occurrence does not imply association. Int J Dermatol 2004;43:699–700
Strauss JS. In: Fitzpatrick’s dermatology in general medicine, 3rd edn, Vol. 1. McGraw Hill, New York, 1987, pp 678–679
Camisa C. Squamous cell carcinoma arising in acne conglobata. Cutis 1984;33:185–187, 190
Thein M, Hogarth MB, Acland K. Seronegative arthritis associated with the follicular occlusion triad. Clin Exp Dermatol 2004;29:550–552
Dufresne RG Jr, Ratz JL, Bergfeld WF, Roenigk RK. Squamous cell carcinoma arising from the follicular occlusion triad. J Am Acad Dermatol 1996;35:475–477
Goldsmith PC, Dowd PM. Successful therapy of the follicular occlusion triad in a young woman with high dose oral antiandrogens and minocycline. J R Soc Med 1993;86:729–730
Olafsson S, Khan MA. Musculoskeletal features of acne, hidradenitis suppurativa, and dissecting cellulitis of the scalp. Rheum Dis Clin North Am 1992;18:215–224
Boyd AS, Zemtsov A. A case of pyoderma vegetans and the follicular occlusion triad. J Dermatol 1992;19:61–63
Curry SS, Gaither DH, King LE Jr. Squamous cell carcinoma arising in dissecting perifolliculitis of the scalp. A case report and review of secondary squamous cell carcinomas. J Am Acad Dermatol 1981;4:673–678
Zisova L, Sakakushev B. Acne tetrad in a family. Folia Med (Plovdiv) 1994;36:51–57
Rosner IA, Richter DE, Huettner TL, Kuffner GH, Wisnieski JJ, Burg CG. Spondyloarthropathy associated with hidradenitis suppurativa and acne conglobata. Ann Intern Med 1982;97:520–525
Rosner IA, Burg CG, Wisnieski JJ, Schacter BZ, Richter DE. The clinical spectrum of the arthropathy associated with hidradenitis suppurativa and acne conglobata. J Rheumatol 1993;20:684–687
Chow ET, Mortimer PS. Successful treatment of hidradenitis suppurativa and retroauricular acne with etretinate. Br J Dermatol 1992;126:415
Scheman AJ. Nodulocystic acne and hidradenitis suppurativa treated with acitretin: a case report. Cutis 2002;69:287–288
Libow LF, Friar DA. Arthropathy associated with cystic acne, hidradenitis suppurativa, and perifolliculitis capitis abscedens et suffodiens: treatment with isotretinoin. Cutis 1999;64:87–90
Hurley HJ. In: Fitzpatrick’s dermatology in general medicine, 3rd edn. McGraw Hill, New York, 1987, pp 712–717
Vahlquist A, Griffiths W. Retinoid therapy in HS — a report of a case. Retinoids Today Tomorrow Issue 1990;18:28–30
Hogan DJ, Light MJ. Successful treatment of hidradenitis suppurativa with acitretin. J Am Acad Dermatol 1988;19:355–356
Stewart WD. The retinoids: a significant advance in dermatology. Medical Education Services, Canada, 1984, p 51
Scheinfeld NS. A case of dissecting cellulitis and a review of the literature. Dermatol Online J 2003;9:8
Bjellerup M, Wallengren J. Familial perifolliculitis capitis abscedens et suffodiens in two brothers successfully treated with isotretinoin. J Am Acad Dermatol 1990;23:752–753
Karpouzis A, Giatromanolaki A, Sivridis E, Kouskoukis C. Perifolliculitis capitis abscedens et suffodiens successfully controlled with topical isotretinoin. Eur J Dermatol 2003;13:192–195
Montgomery JR, White TW, Martin BL, Turner ML, Holland SM. A novel connexin 26 gene mutation associated with features of the keratitis-ichthyosis-deafness syndrome and the follicular occlusion triad. J Am Acad Dermatol 2004;51:377–382
Powell JJ, Dawber RP, Gatter K. Folliculitis decalvans including tufted folliculitis: clinical, histological and therapeutic findings. Br J Dermatol 1999;140:328–333
Schewach-Millet M, Ziv R, Shapira D. Perifolliculitis capitis abscedens et suffodiens treated with isotretinoin (13-cis-retinoic acid). J Am Acad Dermatol 1986;15:1291–1292
Koca R, Altinyazar HC, Ozen OI, Tekin NS. Dissecting cellulitis in a white male: response to isotretinoin. Int J Dermatol 2002;41:509–513
Taylor AE. Dissecting cellulitis of the scalp: response to isotretinoin. Lancet 1987;2(8552):225
Scerri L, Williams HC, Allen BR. Dissecting cellulitis of the scalp: response to isotretinoin. Br J Dermatol 1996;134:1105–1108
Bachynsky T, Antonyshyn OM, Ross JB. Dissecting folliculitis of the scalp. A case report of combined treatment using tissue expansion, radical excision, and isotretinoin. J Dermatol Surg Oncol 1992;18:877–880
Kobayashi H, Aiba S, Tagami H. Successful treatment of dissecting cellulitis and acne conglobata with oral zinc. Br J Dermatol 1999;141:1137–1138
Glass LF, Berman B, Laub D. Treatment of perifolliculitis capitis abscedens et suffodiens with the carbon dioxide laser. J Dermatol Surg Oncol 1989;15:673–676
Boyd AS, Binhlam JQ. Use of an 800-nm pulsed-diode laser in the treatment of recalcitrant dissecting cellulitis of the scalp. Arch Dermatol 2002;138:1291–1293
Chui CT, Berger TG, Price VH, Zachary CB. Recalcitrant scarring follicular disorders treated by laser-assisted hair removal: a preliminary report. Dermatol Surg 1999;25:34–37
Gertsch P, Mosimann R. [Verneuil’s disease in the differential diagnosis of suppuration of the ano-perineo-buttock region.] Helv Chir Acta 1980;47:477–481
Dowling G, Freudenthal W. Acanthosis nigricans. Br J Dermatol 1938;50:467–471
Degos R, Ossipowski B. Dermatose pigmentaire réticulée des plis. Ann Dermatol Syphilol 1954;81:147–151
Berth-Jones J, Graham-Brown RA. A family with Dowling Degos disease showing features of Kitamura’s reticulate acropigmentation. Br J Dermatol 1989;120:463–466
Loo WJ, Rytina E, Todd PM. Hidradenitis suppurativa, Dowling-Degos and multiple epidermal cysts: a new follicular occlusion triad. Clin Exp Dermatol 2004;29:622–624
Cox NH, Long E. Dowling-Degos disease and Kitamura’s reticulate acropigmentation: support for the concept of a single disease. Br J Dermatol 1991;125:169–171
Ostlere L, Holden CA. Dowling-Degos disease associated with Kitamura’s reticulate acropigmentation. Clin Exp Dermatol 1994;19:492–495
Balus L, Fazio M, Amantea A, Menaguale G. [Dowling-Degos disease and Verneuil disease.] Ann Dermatol Venereol 1993;120:705–708
Brown WG. Reticulate pigmented anomaly of the flexures. Case reports and genetic investigation. Arch Dermatol 1982;118:490–493
Crovato F, Rebora A. Reticulate pigmented anomaly of the flexures associating reticulate acropigmentation: one single entity. J Am Acad Dermatol 1986;14:359–361
Crovato F, Nazzari G, Rebora A. Dowling-Degos disease (reticulate pigmented anomaly of the flexures) is an autosomal dominant condition. Br J Dermatol 1983;108:473–476
Rebora A, Crovato F. The spectrum of Dowling-Degos disease. Br J Dermatol 1984;110:627–630
Crovato F, Desirello G, Rebora A. Is Dowling-Degos disease the same disease as Kitamura’s reticulate acropigmentation? Br J Dermatol 1983;109:105–110
Grosshans E, Bouffioux B, Toufik-Bellahcene M. Arguments for the follicular origin of Verneuil’s disease (chronic suppurative hidradenitis). Ann Dermatol Venereol 1991;118:207–209
Wilson Jones E, Grice K. Reticular pigmented anomaly of the flexures. Arch Dermatol 1978;114:1150–1157
Jones EW, Grice K. Reticulate pigmented anomaly of the flexures. Dowling Degos disease, a new genodermatosis. Arch Dermatol 1978;114:1150–1157
Bedlow AJ, Mortimer PS. Dowling-Degos disease associated with hidradenitis suppurativa. Clin Exp Dermatol 1996;21:305–306
Fenske NA, Groover CE, Lober CW, Espinoza CG. Dowling-Degos disease, hidradenitis suppurativa, and multiple keratoacanthomas. A disorder that may be caused by a single underlying defect in pilosebaceous epithelial proliferation. J Am Acad Dermatol 1991;24:888–892
Li M, Hunt MJ, Commens CA. Hidradenitis suppurativa, Dowling Degos disease and perianal squamous cell carcinoma. Aust J Dermatol 1997;38:209–211
Weber LA, Kantor GR, Bergfeld WF. Reticulate pigmented anomaly of the flexures (Dowling-Degos disease): a case report associated with hidradenitis suppurativa and squamous cell carcinoma. Cutis 1990;45:446–450
Tuthill RJ. Dowling-Degos disease associated with hidradenitis suppurativa and squamous cell carcinoma. J Cut Pathol 1990;l7:322
Altomare G, Capella GL, Fracchiolla C, Frigerio E. Effectiveness of topical adapalene in Dowling-Degos disease. Dermatology 1999;198:176–177
Wenzel G, Petrow W, Tappe K, Gerdsen R, Uerlich WP, Bieber T. Treatment of Dowling-Degos disease with Er:YAG-laser: results after 2.5 years. Dermatol Surg 2003;29:1161–1162
Hellmann DB. Spondylarthropathy with hidradenitis suppurativa. J Am Med Assoc 1992;267:2363–2365
Tallo R, Quinet R, Waxman J. Reactive arthritis due to hidradenitis suppurativa mimicking osteomyelitis. South Med J 1991;84:1147–1149
Kenik J, Hurley J. Arthritis occurring with hidradenitis suppurativa. J Rheumatol 1985;12:183–184
Vasey FB, Fenske NA, Clement GB, Bridgeford PH, Germain BF, Espinoza LR. Immunological studies of the arthritis of acne conglobata and hidradenitis suppurativa. Clin Exp Rheumatol 1984;2:309–311
Bennett RE, Wilke WS, Murphy DP. Spondyloarthropathy and hidradenitis suppurativa. Ann Intern Med 1983;98:112
Shenefelt PD. Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen. Cutis 1996;57:315–319
Bhalla R, Sequeira W. Arthritis associated with hidradenitis suppurativa. Ann Rheum Dis 1994;53:64–66
Grassi W, Offidani AM, Blasetti P, Simonetti O, Cervini C. HLA-B27 negative ankylosing spondylitis and hidradenitis suppurativa: report of a case. Clin Rheumatol 1988;7:278–283
Roussomoustakaki M, Dimoulios P, Chatzicostas C, Kritikos HD, Romanos J, Panayiotides JG, Kouroumalis EA. Hidradenitis suppurativa associated with Crohn’s disease and spondyloarthropathy: response to anti-TNF therapy. J Gastroenterol 2003;38:1000–1004
Hamoir XL, Francois RJ, Van den Haute V, Van Campenhoudt M. Arthritis and hidradenitis suppurativa diagnosed in a 48-year-old man. Skeletal Radiol 1999;28:453–456
Leitch DN, Holland CD, Langtry JA. Hidradenitis suppurativa and monoarthritis of the hip. Clin Exp Dermatol 1997;22:206–207
Lapins J, Ye W, Nyren O, Emtestam L. Incidence of cancer among patients with hidradenitis suppurativa. Arch Dermatol 2001;137:730–734
Kaplan RP. Cancer complicating chronic ulcerative scarifying mucocutaneous disorders. Adv Dermatol 1987;2:19–46
Mora RG, Perniciaro C. Cancer of the skin in blacks. I. A review of 163 black patients with cutaneous squamous cell carcinoma. J Am Acad Dermatol 1981;5:535–543
Anderson MJ Jr, Dockerty MB. Perianal hidradenitis suppurativa; a clinical and pathologic study. Dis Colon Rectum 1958;1:23–31
Donsky HJ, Mendelson CG. Squamous cell carcinoma as a complication of hidradenitis suppurativa. Arch Dermatol 1964;90:488–491
Humphrey LJ, Playforth H, Leavell UW Jr. Squamous cell carcinoma arising in hidradenitis suppurativum. Arch Dermatol 1969;100:59–62
Gordon SW. Squamous cell carcinoma arising in hidradenitis suppurativa: case report. Plast Reconstr Surg 1977;60:800–802
Alexander SJ. Squamous cell carcinoma in chronic hidradenitis suppurativa: a case report. Cancer 1979;43:745–748
Black SB, Woods JE. Squamous cell carcinoma complicating hidradenitis suppurativa. J Surg Oncol 1982;19:25–26
Sparks MK, Kuhlman DS, Prieto A, Callen JP. Hypercalcemia in association with cutaneous squamous cell carcinoma. Occurrence as a late complication of hidradenitis suppurativa. Arch Dermatol 1985;121:243–246
Zachary LS, Robson MC, Rachmaninoff N. Squamous cell carcinoma occurring in hidradenitis suppurativa. Ann Plast Surg 1987;18:71–73
Chicarill ZN. Follicular occlusion triad: hidradenitis suppurativa, acne conglobata, and dissecting cellulitis of the scalp. Ann Plast Surg 1987;18:230–237
Anstey AV, Wilkinson JD, Lord P. Squamous cell carcinoma complicating hidradenitis suppurativa. Br J Dermatol 1990;123:527–531
Williams ST, Busby RC, De Muth RJ, Nelson H. Perineal hidradenitis suppurativa: presentation of two unusual complications and a review. Ann Plast Surg 1991;26:456–462
Mendonca H, Rebelo C, Fernandes A, Lino A, Garcia e Silva L. Squamous cell carcinoma arising in hidradenitis suppurativa. J Dermatol Surg Oncol 1991t;17:830–832
Welsh DA, Powers JS. Elevated parathyroid hormone-related protein and hypercalcemia in a patient with cutaneous squamous cell carcinoma complicating hidradenitis suppurativa. South Med J 1993;86:1403–1404
Perez-Diaz D, Calvo-Serrano M, Martinez-Hijosa E, Fuenmayor-Valera L, Munoz-Jimenez F, Turegano-Fuentes F, Del Valle E. Squamous cell carcinoma complicating perianal hidradenitis suppurativa. Int J Colorectal Dis 1995;10:225–228
Shukla VK, Hughes LE. A case of squamous cell carcinoma complicating hidradenitis suppurativa. Eur J Surg Oncol 1995;21:106–109
Lin MT, Breiner M, Fredricks S. Marjolin’s ulcer occurring in hidradenitis suppurativa. Plast Reconstr Surg 1999;103:1541–1543
Cosman BC, O’Grady TC, Pekarske S. Verrucous carcinoma arising in hidradenitis suppurativa. Int J Colorectal Dis 2000;15:342–346
Short KA, Kalu G, Mortimer PS, Higgins EM. Vulval squamous cell carcinoma arising in chronic hidradenitis suppurativa. Clin Exp Dermatol 2005;30:481–483
Rosenzweig LB, Brett AS, Lefaivre JF, Vandersteenhoven JJ. Hidradenitis suppurativa complicated by squamous cell carcinoma and paraneoplastic neuropathy. Am J Med Sci 2005;329:150–152
Altunay IK, Gokdemir G, Kurt A, Kayaoglu S. Hidradenitis suppurativa and squamous cell carcinoma. Dermatol Surg 2002;28:88–90
Manolitsas T, Biankin S, Jaworski R, Wain G. Vulval squamous cell carcinoma arising in chronic hidradenitis suppurativa. Gynecol Oncol 1999;75:285–288
Gur E, Neligan PC, Shafir R, Reznick R, Cohen M, Shpitzer T. Squamous cell carcinoma in perineal inflammatory disease. Ann Plast Surg 1997;38:653–657
Malaguarnera M, Pontillo T, Pistone G, Succi L. Squamous-cell cancer in Verneuil’s disease (hidradenitis suppurativa). Lancet 1996;348(9039):1449
Whipp MJ, Harrington CI, Dundas S. Fatal squamous cell carcinoma associated with acne conglobata in a father and daughter. Br J Dermatol. 1987;117:389–92.
Mahe E, Morelon E, Lechaton S, Sang KH, Mansouri R, Ducasse MF, Mamzer-Bruneel MF, de Prost Y, Kreis H, Bodemer C. Cutaneous adverse events in renal transplant recipients receiving sirolimusbased therapy. Transplantation 2005;79:476–482
Stamm T, Lubach D. [Undesirable side effects on the skin caused by lithium therapy — case report and references (author’s transl).] Psychiatr Prax 1981;8:152–154
Gupta AK, Knowles SR, Gupta MA, Jaunkalns R, Shear NH. Lithium therapy associated with hidradenitis suppurativa: case report and a review of the dermatologic side effects of lithium. J Am Acad Dermatol 1995;32:382–386
Marinella MA. Lithium therapy associated with hidradenitis suppurativa. Acta Dermatol Venereol 1997;77:483
Aithal V, Appaih P. Lithium induced hidradenitis suppurativa and acne conglobata. Indian J Dermatol Venereol Leprol 2004;70:307–309
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Nassif, A.S., Jemec, G.B.E. (2006). Associated Diseases: Causality or Complications?. In: Jemec, G.B.E., Revuz, J., Leyden, J.J. (eds) Hidradenitis Suppurativa. Springer, Berlin, Heidelberg . https://doi.org/10.1007/978-3-540-33101-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-540-33101-8_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-33100-1
Online ISBN: 978-3-540-33101-8
eBook Packages: MedicineMedicine (R0)